Selectins Facilitate Carcinoma Metastasis and Heparin Can Prevent Them

News in Physiological Sciences

Volumn 19, Issue 1, 2004, Pages 16-21

  Borsig, Lubor ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; SELECTIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; L SELECTIN; LOW MOLECULAR WEIGHT HEPARIN; MUCIN; PADGEM PROTEIN;

ANTICOAGULATION; CANCER PATIENT; CANCER PREVENTION; CELL IMMORTALIZATION; CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; EPITHELIUM CELL; HUMAN; LEUKOCYTE ACTIVATION; METASTASIS INHIBITION; METASTASIS POTENTIAL; MICROEMBOLISM; MUCINOUS CARCINOMA; PROGNOSIS; PROTEIN FAMILY; PROTEIN GLYCOSYLATION; PROTEIN SYNTHESIS INHIBITION; REVIEW; THROMBOCYTE AGGREGATION; THROMBOGENESIS; TUMOR CELL; CARCINOGENESIS; CARCINOMA; ENDOTHELIUM CELL; LEUKOCYTE; METASTASIS; PROTEIN EXPRESSION; THROMBOCYTE; TUMOR;

ANTINEOPLASTIC AGENTS; HEPARIN; HUMANS; NEOPLASM METASTASIS; SELECTINS;

EID: 18044368921     PISSN: 08861714     EISSN: None     Source Type: Journal    
DOI: 10.1152/nips.01450.2003     Document Type: Review

References (18)

1. Balkwill F and Mantovani A. Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
2. Biancone L, Araki M, Araki K, Vassalli P, and Stamenkovic I. Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med 183: 581-587, 1996.
3. Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, and Varki A. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 98: 3352-3357, 2001.
4. Borsig L, Wong R, Hynes RO, Varki NM, and Varki A. Synergistic effects of L-and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA 99: 2193-2198, 2002.
5. Callander N and Rapaport SI. Trousseau's syndrome. West J Med 158: 364-371, 1993.
6. Cosgrove RH, Zacharski LR, Racine E, and Andersen JC. Improved cancer mortality with low-molecular-weight heparin treatment: a review of the evidence. Semin Thromb Hemost 28: 79-88, 2002.
7. Coussens LM and Werb Z. Inflammation and cancer. Nature 420: 860-867, 2002.
8. Gasic GJ. Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metastasis Rev 3: 99-114, 1984.
9. Lever R and Page CP. Novel drug development opportunities for heparin. Nat Rev Drug Discov 1: 140-148, 2002.
10. Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J 14: 577-584, 1997.
11. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood 88: 3259-3287, 1996.
12. Kim YJ, Borsig L, Han HL, Varki NM, and Varki A. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol 155: 461-472, 1999.
13. Koenig A, Norgard-Sumnicht K, Linhardt R, and Varki A. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest 101: 877-889, 1998.
14. Nieswandt B, Hafner M, Echtenacher B, and Männel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59: 1295-1300, 1999.
15. Rhodes JM. Usefulness of novel tumour markers. Ann Oncol 10, Suppl 4: 118-121, 1999.
16. Smorenburg SM and Van Noorden JCF. The complex effects of heparins on cancer progression and metastasis in experimental studies. Pharmacol Rev 53: 93-105, 2001.
17. Varki NM and Varki A. Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans. Semin Thromb Hemost 28: 53-68, 2002.
18. Wahrenbrock M, Borsig L, Le D, Varki N, and Varki A. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 112: 853-862, 2003.